首页 > 专栏 > The Lancet Diabetes & Endocrinology The Lancet Diabetes & Endocrinology 共 44 条资讯 [Correspondence] Time for personalised incretin titration 2026-06-28 11:43:57 [Comment] The glucagon renaissance in obesity therapeutics 2026-06-28 11:43:57 [Articles] Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial 2026-06-28 11:43:57 [Editorial] Diabetes in a warming world 2026-06-28 11:43:57 [Comment] Safety and tolerability of orforglipron in Japanese people with type 2 diabetes 2026-06-28 11:43:57 [Articles] Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial 2026-06-28 11:43:57 [In Focus] Toxic chemicals: the fight for planetary health 2026-06-28 11:43:57 [Comment] Type 2 diabetes management: weekly combination therapy comes of age? 2026-06-28 11:43:57 [Articles] Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial 2026-06-28 11:43:57 [Review] Type 1 diabetes in older populations 2026-06-28 11:43:57 [Comment] Less can be more: the 2026 Endocrine Society Guideline for precision care in central precocious puberty 2026-06-28 11:43:57 [Articles] Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis 2026-06-28 11:43:57 [Comment] Redrawing the lines for the management of obesity in Asia 2026-06-28 11:43:57 [Articles] Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial 2026-06-28 11:43:57 [Articles] Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries 2026-06-28 11:43:57 [Corrections] Correction to Lancet Diabetes Endocrinol 2024; 12: 545–57 2026-06-28 11:43:57 [Comment] The risk of biopsy of phaeochromocytomas and paragangliomas 2026-06-28 11:43:57 [Articles] Safety of biopsy in phaeochromocytoma and paraganglioma: an international, multicentre, retrospective cohort study 2026-06-28 11:43:57 [Comment] Are we closer to surpassing residual renal risk in type 2 diabetes? 2026-06-28 11:43:57 [Personal View] Rethinking prophylactic central neck dissection in clinically node-negative papillary thyroid cancer 2026-06-28 11:43:57 « 上一页123下一页 » 相关分类 The Lancet Diabetes & Endocrinology The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi 38号车评中心